NCT05511519Phase 2Terminated
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
Study sponsor: Aclaris Therapeutics, Inc. · ACRS
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2023-12-06Actual
Enrollment · participants47Actual
Source updated2024-11-27Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.